Interferon-alpha in the management of patients with Behçet's disease.
Yang
David S F
DS
UCL Institute of Ophthalmology, Department of Clinical Ophthalmology, Moorfields Eye Hospital, London EC1V 2PD.
Taylor
Simon R J
SR
Lightman
Sue L
SL
D001528:Behcet Syndrome / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D016896:Treatment Outcome; D055815:Young Adult
D007155:Immunologic Factors; D016898:Interferon-alpha